Question 1

Does Rathbones Group own SRNE stock?

Accepted Answer

No. Rathbones Group exited its SRNE (Sorrento Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 40,784 shares worth $395,000.

Question 2

How many shares of SRNE does Rathbones Group own?

Accepted Answer

None since Q3 2021, when Rathbones Group exited the position. Its Q2 2021 13F listed 40,784 shares worth $395,000.

Question 3

What is Rathbones Group's SRNE position worth?

Accepted Answer

Rathbones Group's SRNE position was worth $395,000 in its Q2 2021 13F, before the exit in Q3 2021.

Question 4

Is Rathbones Group buying or selling SRNE?

Accepted Answer

In Q3 2021, Rathbones Group exited its entire SRNE position.

Question 5

When did Rathbones Group first buy SRNE?

Accepted Answer

Rathbones Group first reported SRNE in its Q3 2019 13F and listed it in 8 quarterly 13F filings.